Literature DB >> 19416222

Relaxin signaling in uterine fibroids.

Zhen Li1, Jennifer K Burzawa, Anne Troung, Shu Feng, Irina U Agoulnik, Xiaowen Tong, Matthew L Anderson, Ertug Kovanci, Aleksandar Rajkovic, Alexander I Agoulnik.   

Abstract

Uterine fibroid is the most common tumor of female reproductive organs. The role of relaxin signaling in leiomyoma development was analyzed. We used 23 matched pairs of leiomyoma and normal myometrium samples to compare the expression of relaxin family peptide receptors RXFP1 and RXFP2, caveolin 1, desmin, and steroid receptors and their cofactors, NCOR1 and NCOR2. The expression of RXFP1, evaluated by quantitative reverse transcription-PCR, was downregulated in fibroid tissues. Relaxin or insulin-like peptide 3 treatment suppressed transforming growth factor beta-induced phosphorylation of SMAD2 in rat leiomyoma ELT-3 cells in vitro, suggesting a possible involvement of relaxins in the etiology of leiomyoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416222      PMCID: PMC2954601          DOI: 10.1111/j.1749-6632.2008.03803.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata.

Authors:  Ibrahim Sozen; Aydin Arici
Journal:  Fertil Steril       Date:  2002-07       Impact factor: 7.329

Review 3.  Uterine fibroids: the elephant in the room.

Authors:  Cheryl Lyn Walker; Elizabeth A Stewart
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

4.  Relaxin modulates fibroblast function, collagen production, and matrix metalloproteinase-2 expression by cardiac fibroblasts.

Authors:  Ishanee Mookerjee; Elaine N Unemori; Xiao-Jun DU; Geoffrey W Tregear; Chrishan S Samuel
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

5.  The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.

Authors:  Malte H J Heeg; Michael J Koziolek; Radovan Vasko; Liliana Schaefer; Kumar Sharma; Gerhard A Müller; Frank Strutz
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

6.  Differential expression of transforming growth factor-beta 1 and transforming growth factor-beta receptors in myometrium of women with failed induction of labor, no labor, and preterm labor.

Authors:  N Chegini; C Ma; J Davis; P Duff; C Rosa
Journal:  J Soc Gynecol Investig       Date:  1999 Sep-Oct

7.  Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Authors:  E N Unemori; L B Pickford; A L Salles; C E Piercy; B H Grove; M E Erikson; E P Amento
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

8.  Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.

Authors:  Rosemary Masterson; Tim D Hewitson; Kristen Kelynack; Marina Martic; Laura Parry; Ross Bathgate; Ian Darby; Gavin Becker
Journal:  Nephrol Dial Transplant       Date:  2004-03       Impact factor: 5.992

9.  The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.

Authors:  Nasser Chegini; Xiaoping Luo; Li Ding; Daylene Ripley
Journal:  Mol Cell Endocrinol       Date:  2003-11-14       Impact factor: 4.102

10.  Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis.

Authors:  E N Unemori; L S Beck; W P Lee; Y Xu; M Siegel; G Keller; H D Liggitt; E A Bauer; E P Amento
Journal:  J Invest Dermatol       Date:  1993-09       Impact factor: 8.551

View more
  3 in total

1.  Uterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2.

Authors:  Zhen Li; Shu Feng; Vanessa Lopez; Gina Elhammady; Matthew L Anderson; Elena M Kaftanovskaya; Alexander I Agoulnik
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

2.  Identification of common differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Ioannis Boulalas; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

Review 3.  Transforming growth factor β signaling in uterine development and function.

Authors:  Qinglei Li
Journal:  J Anim Sci Biotechnol       Date:  2014-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.